Nabil Al‐Tawil

693 total citations
22 papers, 407 citations indexed

About

Nabil Al‐Tawil is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Nabil Al‐Tawil has authored 22 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Infectious Diseases. Recurrent topics in Nabil Al‐Tawil's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Phosphodiesterase function and regulation (4 papers) and Influenza Virus Research Studies (2 papers). Nabil Al‐Tawil is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Phosphodiesterase function and regulation (4 papers) and Influenza Virus Research Studies (2 papers). Nabil Al‐Tawil collaborates with scholars based in Sweden, United States and Iraq. Nabil Al‐Tawil's co-authors include Andrea Varrone, Christer Halldin, Jan Persson, Ingegerd Odar‐Cederlöf, Sangram Nag, Fons Bosman, Rigmor Thorstensson, Nathalie Mielcarek, Jakob Bergström and Camille Locht and has published in prestigious journals such as Blood, PLoS ONE and NeuroImage.

In The Last Decade

Nabil Al‐Tawil

22 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nabil Al‐Tawil Sweden 11 112 93 89 83 61 22 407
R. Nau Germany 8 73 0.7× 119 1.3× 113 1.3× 21 0.3× 32 0.5× 28 369
Philip L. Fisette United States 10 186 1.7× 73 0.8× 72 0.8× 56 0.7× 32 0.5× 10 723
Ping-Yu Lee Taiwan 16 185 1.7× 147 1.6× 161 1.8× 30 0.4× 207 3.4× 26 719
Maira Soto United States 9 67 0.6× 30 0.3× 49 0.6× 42 0.5× 25 0.4× 15 314
N. Friedmann United States 13 97 0.9× 76 0.8× 72 0.8× 180 2.2× 163 2.7× 27 639
Brenda J. Curtis United States 15 163 1.5× 157 1.7× 15 0.2× 48 0.6× 21 0.3× 30 533
Hirofumi Ohtaki Japan 13 160 1.4× 108 1.2× 19 0.2× 63 0.8× 30 0.5× 23 526
P Lapalus France 16 213 1.9× 82 0.9× 13 0.1× 39 0.5× 87 1.4× 71 717
Miloš Marković Serbia 15 88 0.8× 73 0.8× 12 0.1× 52 0.6× 47 0.8× 50 610
Qijie Li China 9 206 1.8× 47 0.5× 37 0.4× 69 0.8× 16 0.3× 22 415

Countries citing papers authored by Nabil Al‐Tawil

Since Specialization
Citations

This map shows the geographic impact of Nabil Al‐Tawil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Al‐Tawil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Al‐Tawil more than expected).

Fields of papers citing papers by Nabil Al‐Tawil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Al‐Tawil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Al‐Tawil. The network helps show where Nabil Al‐Tawil may publish in the future.

Co-authorship network of co-authors of Nabil Al‐Tawil

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Al‐Tawil. A scholar is included among the top collaborators of Nabil Al‐Tawil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Al‐Tawil. Nabil Al‐Tawil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandberg, John Tyler, Renata Varnaitė, Johanna Emgård, et al.. (2023). Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. PLoS neglected tropical diseases. 17(2). e0010616–e0010616. 6 indexed citations
2.
Fazio, Patrik, Cheryl Fitzer‐Attas, Ladislav Mrzljak, et al.. (2020). PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression. Movement Disorders. 35(4). 606–615. 21 indexed citations
3.
Sardh, Eliane, Manisha Balwani, Pauline Harper, et al.. (2018). A phase 1/2, randomized, placebo controlled and open label extension studies of Givosiran and investigational RNA interference therapeutic, in patients with acute intermittent porphyria. Journal of Hepatology. 68. S66–S67. 3 indexed citations
4.
Delnomdedieu, Marielle, Anton Forsberg, Adam Ogden, et al.. (2017). In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects. Neuropharmacology. 117. 171–181. 22 indexed citations
5.
6.
Schain, Martin, Patrik Fazio, Ladislav Mrzljak, et al.. (2017). Revisiting the Logan plot to account for non-negligible blood volume in brain tissue. EJNMMI Research. 7(1). 66–66. 8 indexed citations
7.
Jerling, Markus, et al.. (2017). Effects of intranasal kinetic oscillation stimulation on heart rate variability. Annals of Noninvasive Electrocardiology. 23(1). 3 indexed citations
8.
Forsberg, Anton, Stephane Navé, Per Stenkrona, et al.. (2016). Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline. European Journal of Nuclear Medicine and Molecular Imaging. 44(3). 382–391. 21 indexed citations
9.
Neimert-Andersson, Theresa, Jonas Binnmyr, Mattias Enoksson, et al.. (2014). Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial. Vaccine. 32(45). 5967–5974. 31 indexed citations
10.
11.
Fazio, Patrik, Cheryl Fitzer‐Attas, Ladislav Mrzljak, et al.. (2014). E31 Positron Emission Tomography Imaging Of Phosphodiesterase 10 A Enzyme And Dopamine D2 Receptor In Huntington's Disease Gene Expansion Carriers. Journal of Neurology Neurosurgery & Psychiatry. 85(Suppl 1). A47–A47. 2 indexed citations
12.
Varrone, Andrea, Anton Forsberg, Akihiro Takano, et al.. (2013). In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 921–931. 64 indexed citations
13.
Ricci, Benedicte, Nicholas Seneca, Candice Jamois, et al.. (2013). P3–300: Brain MAO‐B inhibition in healthy elderly and people with Alzheimer's disease after oral administration of RO4602522. Alzheimer s & Dementia. 9(4S_Part_17). 2 indexed citations
14.
Al‐Tawil, Nabil, et al.. (2012). Pharmacokinetics of transdermal buprenorphine patch in the elderly. European Journal of Clinical Pharmacology. 69(2). 143–149. 44 indexed citations
15.
Al‐Tawil, Nabil, et al.. (1994). Contact sensitivity among workers in a paint factory. Contact Dermatitis. 30(1). 55–57. 2 indexed citations
16.
Marcus, Stanley, et al.. (1993). Virological and Immunological Studies in Patients with Acute Viral Hepatitis. Scandinavian Journal of Immunology. 37(2). 265–270. 5 indexed citations
17.
Al‐Tawil, Nabil, Jan A. Marcusson, & E Möller. (1985). T and B Lymphocytes in Patients with Nickel Sensitivity. Scandinavian Journal of Immunology. 22(5). 495–502. 4 indexed citations
18.
Al‐Tawil, Nabil, Jan A. Marcusson, & Erna Möller. (1985). HLA‐class II restriction of the proliferative T lymphocyte responses to nickel, cobalt and chromium compounds. Tissue Antigens. 25(3). 163–172. 11 indexed citations
19.
Yaseen, Nahi Y., et al.. (1980). Trial of immunopotentiation by levamisole in patients with pulmonary tuberculosis. Journal of Infection. 2(2). 125–136. 3 indexed citations
20.
Al‐Tawil, Nabil, et al.. (1978). Study of the Immunological Status of Patients with Pulmonary Tuberculosis. Scandinavian Journal of Immunology. 8(4). 333–338. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Nau Breakdown of academic impact, for papers by Philip L. Fisette Breakdown of academic impact, for papers by Ping-Yu Lee Breakdown of academic impact, for papers by Maira Soto Breakdown of academic impact, for papers by N. Friedmann Breakdown of academic impact, for papers by Brenda J. Curtis Breakdown of academic impact, for papers by Hirofumi Ohtaki Breakdown of academic impact, for papers by P Lapalus Breakdown of academic impact, for papers by Miloš Marković Breakdown of academic impact, for papers by Qijie Li
Rankless by CCL
2026